3-Methyl-2-chloro-6-ethyl-pyridine | 125015-01-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-Methyl-2-chloro-6-ethyl-pyridine
• 英文别名: 2-Chloro-6-ethyl-3-methylpyridine
• CAS: 125015-01-2
• 化学式: C₈H₁₀ClN
• 分子量: 155.627
• InChiKey: BGXCIXUNQJVWIJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  Nitrile of 2-Methyl-2-chloro-5-oxoheptanoic Acid 在 盐酸 、 三氯氧磷 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以81%的产率得到3-Methyl-2-chloro-6-ethyl-pyridine
  参考文献：
  名称：

  Halogen-substituted pyridines. 3. Cyclization of adducts of ?,?-dichloropropionitrile with acrylic derivatives to chloropyridines

  摘要：

  DOI：

  10.1007/bf00480759

文献信息

• PROTEIN-TARGETING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
  申请人：BioTheryX, Inc.

  公开号：US20200369679A1

  公开（公告）日：2020-11-26

  The present disclosure provides compounds, for example, a compound of Formula (I), that modulate a protein function and/or restore protein homeostasis. The disclosure provides a method of modulating a protein-mediated disease, disorder, condition, or response. Compositions, including in combination with other therapeutic agents, are provided.

  本公开提供了化合物，例如式（I）的化合物，其调节蛋白功能和/或恢复蛋白稳态。该公开提供了一种调节蛋白介导的疾病、紊乱、状况或反应的方法。还提供了与其他治疗剂结合的组合物。
• [EN] ATR INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS D'ATR ET LEURS UTILISATIONS
  申请人：SHANGHAI ANTENGENE CORPORATION LTD

  公开号：WO2022002245A1

  公开（公告）日：2022-01-06

  The present disclosure relates to novel compounds useful as inhibitors of ATR kinase, as well as pharmaceutical compositions comprising these compounds and methods of treatment by administration of these compounds or the pharmaceutical compositions.

  本公开涉及作为ATR激酶抑制剂有用的新化合物，以及包含这些化合物的药物组合物和通过给予这些化合物或药物组合物进行治疗的方法。
• Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications
  申请人：BioTheryX, Inc.

  公开号：US11345712B2

  公开（公告）日：2022-05-31

  The present disclosure provides compounds, for example, a compound of Formula (I), that modulate a protein function and/or restore protein homeostasis. The disclosure provides a method of modulating a protein-mediated disease, disorder, condition, or response. Compositions, including in combination with other therapeutic agents, are provided.

  本公开提供了调节蛋白质功能和/或恢复蛋白质平衡的化合物，例如式（I）化合物。本公开提供了一种调节蛋白质介导的疾病、失调、状况或反应的方法。提供了包括与其他治疗剂组合的组合物。
• SHVEXGEJMER, M. -G. A.;KOBRAKOV, K. I.;SYCHEV, S. S.;PROMONENKOV, V. K., XIMIYA GETEROTSIKL. SOED.,(1989) N, S. 514-519
  作者：SHVEXGEJMER, M. -G. A.、KOBRAKOV, K. I.、SYCHEV, S. S.、PROMONENKOV, V. K.

  DOI：——

  日期：——
• AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS
  申请人：Janssen Pharmaceutica NV

  公开号：US20180118740A1

  公开（公告）日：2018-05-03

  Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods of using compounds of Formula (I).